Shenzhen Neptunus Bioengineering Co Ltd
SZSE:000078

Watchlist Manager
Shenzhen Neptunus Bioengineering Co Ltd Logo
Shenzhen Neptunus Bioengineering Co Ltd
SZSE:000078
Watchlist
Price: 3.61 CNY 4.64% Market Closed
Market Cap: ¥9.5B

Wall Street
Price Targets

Price Targets Summary
Shenzhen Neptunus Bioengineering Co Ltd

There are no price targets for Shenzhen Neptunus Bioengineering Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Shenzhen Neptunus Bioengineering Co Ltd Competitors:
Price Targets
CAH
Cardinal Health Inc
18% Upside
JMT
JMT Network Services PCL
18% Upside

Revenue
Forecast

14% / Year
Past Growth
-3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
14% / Year
Past Growth
-3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Shenzhen Neptunus Bioengineering Co Ltd's revenue is 14%. The projected CAGR for the next 7 years is -3%.

Operating Income
Forecast

-1% / Year
Past Growth
24% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-1% / Year
Past Growth
24% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 13 years the compound annual growth rate for Shenzhen Neptunus Bioengineering Co Ltd's operating income is -1%. The projected CAGR for the next 9 years is 24%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shenzhen Neptunus Bioengineering Co Ltd's stock price target?
Not Available

Shenzhen Neptunus Bioengineering Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Shenzhen Neptunus Bioengineering Co Ltd's Revenue forecast?
Projected CAGR
-3%

For the last 13 years the compound annual growth rate for Shenzhen Neptunus Bioengineering Co Ltd's revenue is 14%. The projected CAGR for the next 7 years is -3%.

What is Shenzhen Neptunus Bioengineering Co Ltd's Operating Income forecast?
Projected CAGR
24%

For the last 13 years the compound annual growth rate for Shenzhen Neptunus Bioengineering Co Ltd's operating income is -1%. The projected CAGR for the next 9 years is 24%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett